All

Maat Pharma and Skyepharma have entered a partnership to establish the first exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France
14 February 2022

Maat Pharma and Skyepharma have entered a partnership to establish the first exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France

MaaT Pharma (EURONEXT: MAAT), a French clinical-stage biotech (Phase 3) and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival...

Read the press release
Seventure Partners expands focus to ‘blue’ economy BlueForwardFund™ announces first close, with the support of the Banque Populaire banks
11 February 2022

Seventure Partners expands focus to ‘blue’ economy BlueForwardFund™ announces first close, with the support of the Banque Populaire banks

Seventure Partners (Seventure), one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, under the leadership of Isabelle de...

Read the press release
The start-up La Vie™ raises €25M and sets out to conquer the world with its new generation of plant-based meat
19 January 2022

The start-up La Vie™ raises €25M and sets out to conquer the world with its new generation of plant-based meat

The first record raising of €25M in Series A financing from investment funds led by Seventure, and international celebrities that are committed to protecting the planet. This...

Read the press release
Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge
13 January 2022

Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge

DERMALA, a consumer dermatology company that develops novel treatments for chronic skin conditions, announces the brand's Grand Prize recognition in the global pitch...

Read more
Prestashop acquired by MBE Worldwide
25 November 2021

Prestashop acquired by MBE Worldwide

MBE and PrestaShop join forces to become a leading global commerce platform to power business growth.

Read more
Three Startups Win First-Ever Colgate Connect Challenge
10 January 2022

Three Startups Win First-Ever Colgate Connect Challenge

Colgate-Palmolive is pleased to announce the winners of the Colgate Connect Challenge, its first-ever global pitch competition aimed at startups from around the world focused...

Read more
MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.
15 December 2021

MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.

MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in developing...

Read the press release
MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan
17 November 2021

MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan

MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announces today the regulatory clearance and marketing approval of its HFVI...

Read the press release
MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris
3 November 2021

MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris

MaaT Pharma S.A. ("MaaT Pharma" or the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome2-based ecosystem therapies dedicated to...

Read the press release
Axial Therapeutics Receives FDA Clearance of IND Application and Initiates Phase 2b Trial for AB-2004, Lead Gut-Targeted, Molecular Therapeutic for the Treatment of Irritability in Autism Spectrum Disorder
27 October 2021

Axial Therapeutics Receives FDA Clearance of IND Application and Initiates Phase 2b Trial for AB-2004, Lead Gut-Targeted, Molecular Therapeutic for the Treatment of Irritability in Autism Spectrum Disorder

Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and diseases, today announced that the...

Read the press release